国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Haemophilus ducreyi Serine--tRNA ligase (serS) CSB-YP746219HSY
CSB-EP746219HSY
CSB-BP746219HSY
CSB-MP746219HSY
CSB-EP746219HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Methionine import ATP-binding protein MetN (metN) CSB-YP746220HSY
CSB-EP746220HSY
CSB-BP746220HSY
CSB-MP746220HSY
CSB-EP746220HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Histidine--tRNA ligase (hisS) CSB-YP746221HSY
CSB-EP746221HSY
CSB-BP746221HSY
CSB-MP746221HSY
CSB-EP746221HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Cell division protein ZapA (zapA) CSB-YP746222HSY
CSB-EP746222HSY
CSB-BP746222HSY
CSB-MP746222HSY
CSB-EP746222HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Acetylglutamate kinase (argB) CSB-YP746223HSY
CSB-EP746223HSY
CSB-BP746223HSY
CSB-MP746223HSY
CSB-EP746223HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Chromosomal replication initiator protein DnaA (dnaA) CSB-YP746224HSY
CSB-EP746224HSY
CSB-BP746224HSY
CSB-MP746224HSY
CSB-EP746224HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP746225HSY
CSB-EP746225HSY
CSB-BP746225HSY
CSB-MP746225HSY
CSB-EP746225HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Cytochrome c biogenesis ATP-binding export protein CcmA (ccmA) CSB-YP746226HSY
CSB-EP746226HSY
CSB-BP746226HSY
CSB-MP746226HSY
CSB-EP746226HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi D-tyrosyl-tRNA (Tyr) deacylase (dtd) CSB-YP746227HSY
CSB-EP746227HSY
CSB-BP746227HSY
CSB-MP746227HSY
CSB-EP746227HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Magnesium transport protein CorA (corA), partial CSB-YP746228HSY1
CSB-EP746228HSY1
CSB-BP746228HSY1
CSB-MP746228HSY1
CSB-EP746228HSY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Valine--tRNA ligase (valS), partial CSB-YP746229HSY
CSB-EP746229HSY
CSB-BP746229HSY
CSB-MP746229HSY
CSB-EP746229HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Ribosomal RNA small subunit methyltransferase J (rsmJ) CSB-YP746230HSY
CSB-EP746230HSY
CSB-BP746230HSY
CSB-MP746230HSY
CSB-EP746230HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Selenide, water dikinase (selD) CSB-YP746231HSY
CSB-EP746231HSY
CSB-BP746231HSY
CSB-MP746231HSY
CSB-EP746231HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Glycerol-3-phosphate acyltransferase (plsB), partial CSB-YP746232HSY
CSB-EP746232HSY
CSB-BP746232HSY
CSB-MP746232HSY
CSB-EP746232HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi DNA-binding protein fis (fis) CSB-YP746233HSY
CSB-EP746233HSY
CSB-BP746233HSY
CSB-MP746233HSY
CSB-EP746233HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Shikimate dehydrogenase (aroE) CSB-YP746234HSY
CSB-EP746234HSY
CSB-BP746234HSY
CSB-MP746234HSY
CSB-EP746234HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Electron transport complex protein RnfA (rnfA), partial CSB-YP746235HSY1
CSB-EP746235HSY1
CSB-BP746235HSY1
CSB-MP746235HSY1
CSB-EP746235HSY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Fe/S biogenesis protein NfuA (nfuA) CSB-YP746236HSY
CSB-EP746236HSY
CSB-BP746236HSY
CSB-MP746236HSY
CSB-EP746236HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Peptide chain release factor 3 (prfC), partial CSB-YP746237HSY
CSB-EP746237HSY
CSB-BP746237HSY
CSB-MP746237HSY
CSB-EP746237HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi UPF0133 protein HD_0326 (HD_0326) CSB-YP746238HSY
CSB-EP746238HSY
CSB-BP746238HSY
CSB-MP746238HSY
CSB-EP746238HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>